US2017247329A1PendingUtilityA1
"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones"
Est. expiryJul 3, 2029(~2.9 yrs left)· nominal 20-yr term from priority
Inventors:Tim Fat TamRegis Leung-ToungYingsheng WangYanqing ZhaoTao XinBirenkumar ShahBlaise N'ZembaJolanta Maria WodzinskaMaryna Premyslova
A61P 35/00A61P 39/04A61P 25/00A61P 25/28A61P 13/00A61P 13/12A61P 11/00C07D 213/69C07D 211/88A61K 31/4412C07D 213/79C07D 211/86C07D 213/26C07D 401/06A61K 31/496A61K 31/4545C07D 213/74
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.
Claims
exact text as granted — not AI-modified1 . A compound of Formula I:
wherein
G 1 is H, C 1 -C 4 alkyl or CH 2 OH;
G 2 is (CH 2 ) n CF 2 R 3 , where n is 1, and R 3 is H or F;
G 3 is H or Ci-C4 alkyl; and
G 4 is H.
2 . (canceled)
3 . The compound of claim 1 wherein R 3 is F.
4 .- 5 . (canceled)
6 . The compound of claim 3 wherein G 1 is ethyl, and G 3 is H.
7 .- 10 . (canceled)
11 . A method of treating a medical condition related to a toxic concentration of iron, wherein the method comprises administering to a subject having or suspected of having a medical condition related to a toxic concentration of iron, an effect amount of a compound of formula 1.
12 . The method of claim 11 wherein the medical condition related to a toxic concentration of iron is selected from the group consisting of cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.Join the waitlist — get patent alerts
Track US2017247329A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.